Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease
- PMID: 8667008
- DOI: 10.1046/j.1471-4159.1996.67010317.x
Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease
Abstract
We examined protein kinase C (PKC) activity in Ca2+-dependent PKC (Ca2+-dependent PKC activities) and Ca2+-independent PKC (Ca2+-independent PKC activities) assay conditions in brains from Alzheimer's disease (AD) patients and age-matched controls. In cytosolic and membranous fractions, Ca2+-dependent and Ca2+-independent PKC activities were significantly lower in AD brain than in control brain. In particular, reduction of Ca2+-independent PKC activity in the membranous fraction of AD brain was most enhanced when cardiolipin, the optimal stimulator of PKC-epsilon, was used in the assay; whereas Ca2+-independent PKC activity stimulated by phosphatidylinositol, the optimal stimulator of PKC-delta, was not significantly reduced in AD. Further studies on the protein levels of Ca2+-independent PKC-delta, PKC-epsilon and PKC-zeta in AD brain revealed reduction of the PKC-epsilon level in both cytosolic and membranous fractions, although PKC-delta and PKC-zeta levels were not changed. These findings indicated that Ca2+-dependent and Ca2+-independent PKC are changed in AD, and that among Ca2+-independent PKC isozymes, the alteration of PKC-epsilon is a specific event in AD brain, suggesting its crucial role in AD pathophysiology.
Similar articles
-
Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.Neurobiol Aging. 1994 May-Jun;15(3):293-8. doi: 10.1016/0197-4580(94)90023-x. Neurobiol Aging. 1994. PMID: 7936052
-
Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.Neurology. 1993 Jul;43(7):1407-13. doi: 10.1212/wnl.43.7.1407. Neurology. 1993. PMID: 8327146
-
Expression and activity of protein kinase C isoenzymes during normal and abnormal murine palate development.J Craniofac Genet Dev Biol. 2000 Jan-Mar;20(1):26-34. J Craniofac Genet Dev Biol. 2000. PMID: 10879655
-
Protein kinase C-epsilon (PKC-epsilon): its unique structure and function.J Biochem. 2002 Dec;132(6):847-52. doi: 10.1093/oxfordjournals.jbchem.a003296. J Biochem. 2002. PMID: 12473185 Review.
-
Protein kinase C pharmacology: perspectives on therapeutic potentials as antidementic and cognitive agents.Recent Pat CNS Drug Discov. 2006 Jun;1(2):147-56. doi: 10.2174/157488906777452721. Recent Pat CNS Drug Discov. 2006. PMID: 18221200 Review.
Cited by
-
PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.J Neurosci. 2011 Jan 12;31(2):630-43. doi: 10.1523/JNEUROSCI.5209-10.2011. J Neurosci. 2011. PMID: 21228172 Free PMC article.
-
Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.Mol Pathol. 1997 Jun;50(3):124-31. doi: 10.1136/mp.50.3.124. Mol Pathol. 1997. PMID: 9292146 Free PMC article. Review. No abstract available.
-
Activation of LA-N-2 cell phospholipase D by amyloid beta protein (25-35).Neurochem Res. 1998 Oct;23(10):1225-32. doi: 10.1023/a:1020731813973. Neurochem Res. 1998. PMID: 9804277
-
Analysis of Differentially Expressed Genes Associated With Alzheimer's Disease Based on Bioinformatics Methods.Am J Alzheimers Dis Other Demen. 2015 Dec;30(8):746-51. doi: 10.1177/1533317514537548. Epub 2014 Jun 24. Am J Alzheimers Dis Other Demen. 2015. PMID: 24965283 Free PMC article.
-
Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.Mol Neurobiol. 1998 Feb;16(1):49-62. doi: 10.1007/BF02740602. Mol Neurobiol. 1998. PMID: 9554701 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous